U
MBII

UBS’s Marrone Bio Innovations, Inc. MBII Stock Holding History

UBS’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+200
New +$1.34K ﹤0.01% 10207

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
OIM
Orca Investment Management Roseburg, Oregon $118M AUM 36.88% 1-Year Est. Return

UBS's MBII Position: Q3 2014 in Review

UBS increased its Marrone Bio Innovations, Inc. (MBII) stake by 36% in Q3 2014, buying an estimated $2.46K and bringing the position to 1,400 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9671.

UBS first reported a position in MBII in Q4 2013 and has held it in 4 quarters since. The position peaked at $12K in Q2 2014. 49 funds tracked by Wall St. Rank hold MBII as of Q3 2014.

  • UBS held 1,400 shares of Marrone Bio Innovations, Inc. worth $4K as of Q3 2014.
  • UBS bought 368 Marrone Bio Innovations, Inc. shares in Q3 2014, an estimated $2.46K.
  • Marrone Bio Innovations, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9671 holding.
  • UBS first reported a position in Marrone Bio Innovations, Inc. in Q4 2013 and has held it in 4 quarters since.
  • UBS's Marrone Bio Innovations, Inc. position peaked at $12K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.